Dr. Axel Grothey: The Failure of Clinical Trials of Adjuvant Therapy in Colorectal Cancer Is Sobering
Dr. Axel Grothey: The Failure of Clinical Trials of Adjuvant Therapy in Colorectal Cancer Is Sobering
Interview by L Scott Zoeller
20110019
2011 Jan 19
Top Stories of 2010
Dr. Axel Grothey: The Failure of Clinical Trials of Adjuvant Therapy in Colorectal Cancer Is Sobering
Top Stories of 2010. 2011 Jan 19, Interview by L Scott Zoeller
Abstract
Dr. Grothey is Professor of Oncology; Consultant, Medical Oncology at the Mayo Clinic in Rochester, MN. OncologySTAT: In your view, which development in colorectal cancer that occurred in 2010 could have the most significant impact on oncology?Dr. Grothey: Unfortunately, colorectal cancer was impacted mostly by failures. We still have not moved colorectal cancer therapy forward in the adjuvant setting beyond integrating oxaliplatin into our treatment regimens. The large studies that were presented...
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
